Clinical Trial Update: A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety and effects of intramuscular onabotulinumtoxinA (BOTOX) for platysma prominence; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platysma Prominence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: AbbVie | Conditions: Platysma Prominence | Phase 3 | Status: COMPLETED | Results posted: 2024-08-20